ATE227123T1 - Transdermales pflaster, das festes methylphenidat beinhaltet - Google Patents

Transdermales pflaster, das festes methylphenidat beinhaltet

Info

Publication number
ATE227123T1
ATE227123T1 AT98303685T AT98303685T ATE227123T1 AT E227123 T1 ATE227123 T1 AT E227123T1 AT 98303685 T AT98303685 T AT 98303685T AT 98303685 T AT98303685 T AT 98303685T AT E227123 T1 ATE227123 T1 AT E227123T1
Authority
AT
Austria
Prior art keywords
methylphenidate
transdermal patch
containing solid
patch containing
stimulant
Prior art date
Application number
AT98303685T
Other languages
English (en)
Inventor
Chester Sapino
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10813192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE227123(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Application granted granted Critical
Publication of ATE227123T1 publication Critical patent/ATE227123T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98303685T 1997-05-30 1998-05-12 Transdermales pflaster, das festes methylphenidat beinhaltet ATE227123T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9711032.4A GB9711032D0 (en) 1997-05-30 1997-05-30 Compound as a stimulant for the central nervous system

Publications (1)

Publication Number Publication Date
ATE227123T1 true ATE227123T1 (de) 2002-11-15

Family

ID=10813192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98303685T ATE227123T1 (de) 1997-05-30 1998-05-12 Transdermales pflaster, das festes methylphenidat beinhaltet

Country Status (10)

Country Link
US (1) US6096760A (de)
EP (1) EP0881216B1 (de)
JP (1) JPH1143486A (de)
CN (1) CN1158260C (de)
AT (1) ATE227123T1 (de)
AU (1) AU726662B2 (de)
CA (1) CA2239313C (de)
DE (1) DE69809124T2 (de)
GB (1) GB9711032D0 (de)
TW (1) TW424086B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210705B1 (en) 1997-12-15 2001-04-03 Noven Pharmaceuticals, Nc. Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
GB9918735D0 (en) * 1999-08-09 1999-10-13 Straken Limited Transdermal patches
CA2420569A1 (en) * 2000-08-28 2002-03-07 Mel H. Epstein Use of threo-methylphenidate compounds to enhance memory
AU2001286861A1 (en) * 2000-08-28 2002-03-13 Sention, Inc. Use of methylphenidate compounds to enhance memory
US7897777B2 (en) * 2007-01-05 2011-03-01 Archimica, Inc. Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate
CN105395523A (zh) * 2015-11-25 2016-03-16 上海现代药物制剂工程研究中心有限公司 包含白斑抑制剂的右哌甲酯骨架型透皮贴剂及制法和应用
WO2019167695A1 (ja) * 2018-02-27 2019-09-06 久光製薬株式会社 ケイ酸カルシウムを含有するアクリル系貼付剤

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH269656A (de) * 1944-01-19 1950-07-15 Ciba Geigy Verfahren zur Herstellung einer neuen Piperidinverbindung.
US2507631A (en) * 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
GB589625A (en) * 1944-01-19 1947-06-25 Chem Ind Basel Manufacture of new pyridine and piperidine compounds
CH269338A (de) * 1944-01-19 1950-06-30 Ciba Geigy Verfahren zur Herstellung einer neuen Piperidinverbindung.
US2838519A (en) * 1953-12-23 1958-06-10 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
US4201211A (en) * 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
DE2924005C2 (de) * 1979-06-13 1984-07-05 Sanol Schwarz-Monheim Gmbh, 4019 Monheim Isosorbiddinitrat enthaltendes Mittel
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4341208A (en) * 1980-07-14 1982-07-27 Whitman Medical Corporation Moisture-retentive covering for ointment application
US4379454A (en) * 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4559222A (en) * 1983-05-04 1985-12-17 Alza Corporation Matrix composition for transdermal therapeutic system
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US5318960A (en) * 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances

Also Published As

Publication number Publication date
AU6709598A (en) 1998-12-03
DE69809124T2 (de) 2003-06-18
US6096760A (en) 2000-08-01
EP0881216A1 (de) 1998-12-02
CN1158260C (zh) 2004-07-21
JPH1143486A (ja) 1999-02-16
EP0881216B1 (de) 2002-11-06
GB9711032D0 (en) 1997-07-23
CA2239313C (en) 2007-12-04
CA2239313A1 (en) 1998-11-30
TW424086B (en) 2001-03-01
DE69809124D1 (de) 2002-12-12
CN1201033A (zh) 1998-12-09
AU726662B2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
DE68908786D1 (de) Condensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE68913831D1 (de) Kondensierte Pyrimidinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
PT91850A (pt) Processo para a preparacao de formulacoes farmaceuticas com material biologicamente activo particularmente material proteinaceo
AU1302499A (en) Buffered drug formulations for transdermal electrotransport delivery
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
IT1232149B (it) Composizione farmaceutica contenente ranitidina, e metodo per prepararla
DE69007592D1 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
DE69830584D1 (de) 2-(iminomethyl)aminophenyl-derivate, deren herstellung, verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
FI871313A7 (fi) Menetelmä lääkeadsorbaattien valmistamiseksi.
AU4464897A (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU7662400A (en) Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin
KR900700492A (ko) N-헤테로사이클릭 프로필리덴-1,1-비스포스폰산, 이의 제조방법 및 약제학적 조성물
FI905439A7 (fi) Uudet insuliinijohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö ja niitä sisältävä farmaseuttinen valmiste
AU2049388A (en) Transdermal administration using benzyl alcohol
DE69809124D1 (de) Transdermales Pflaster, das festes Methylphenidat beinhaltet
DE3766299D1 (de) 4-chinolon-3-carbonsaeurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
FI953532A7 (fi) Nitroglyserolia sisältävä laastari, menetelmä sen valmistamiseksi ja s en käyttö
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
FI896243A7 (fi) N-pyridinyyli-9H-karbatsoli-9-amiineja, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
ATE244246T1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties